BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Diabetes mellitus
,
Retina
,
Pharmacogenetics
,
Rosiglitazone
,
rs6983267
,
KLK3
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
Efavirenz
(compound)
Summary
General Info
Genetic Markers
Most Correlated Genes
No genes found
Explore Genetic Markers Results
Pathway Enrichment
Most Correlated Biogroups
No biogroups found
Explore Pathway Enrichment Results
Curated Studies
Most Correlated Studies
Adipose tissue of HIV+ patients undergoing different anti-viral treatments
L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (1 of 4)
L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (2 of 4)
L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (3 of 4)
Explore Curated Studies Results
Literature
Most Relevant Literature
Stability and intrinsic dissolution of vacuum compression molded amorphous solid dispersions of efav…
Nicotine Metabolite Ratio Decreases After Switching Off Efavirenz-Based Therapy in People With HIV W…
7,8-Dihydroxy Efavirenz Is Not as Effective in CYP46A1 Activation In Vivo as Efavirenz or Its 8,14-D…
Electroencephalography as a diagnostic tool for late-onset efavirenz neurotoxicity syndrome.
Mechanistic Modeling of the Drug-Drug Interaction Between Efavirenz and Dolutegravir: Is This Intera…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Efavirenz Comparative Bioavailability
Pharmacokinetics of Efavirenz in the Presence of Rifampicin and Isoniazid
Effects of CYP2B6 Genetic Polymorphisms on Efavirenz Pharmacokinetics
Drug-Drug Interaction Study Between Fenofibric Acid and Efavirenz
A Study of Efavirenz in Combination With Stavudine and Didanosine
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ